{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:41:14Z","timestamp":1791686474894,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1124\/dmd.109.030197","type":"journal-article","created":{"date-parts":[[2009,12,18]],"date-time":"2009-12-18T02:26:35Z","timestamp":1261103195000},"page":"516-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":269,"title":["Stable Expression, Activity, and Inducibility of Cytochromes P450 in Differentiated HepaRG Cells"],"prefix":"10.1016","volume":"38","author":[{"given":"S\u00e9bastien","family":"Anth\u00e9rieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chesn\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoya","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Camus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Lahoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Picazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miia","family":"Turpeinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Tolonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Uusitalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Guguen-Guillouzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Guillouzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.109.030197_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/dmd.105.006759","article-title":"Expression of cytochromes P450, conjugating enzymes and nuclear receptors in human hepatoma HepaRG cells","volume":"34","author":"Aninat","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib2","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/hep.21536","article-title":"Transdifferentiation of hepatocyte-like cells from the human hepatoma HepaRG cell line through bipotent progenitor","volume":"45","author":"Cerec","year":"2007","journal-title":"Hepatology"},{"key":"10.1124\/dmd.109.030197_bib3","first-page":"23","article-title":"A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry","volume":"29","author":"Dierks","year":"2001","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib4","series-title":"Guidance for Industry: Bioanalytical Method Validation","year":"2001"},{"key":"10.1124\/dmd.109.030197_bib5","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1124\/dmd.105.005173","article-title":"Simultaneous measurement of 23 isoforms from the human cytochrome P450 families 1 to 3 by quantitative reverse transcriptase-polymerase chain reaction","volume":"33","author":"Girault","year":"2005","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/1389200043335414","article-title":"Human hepatocytes in primary culture: the choice to investigate drug metabolism in man","volume":"5","author":"G\u00f3mez-Lech\u00f3n","year":"2004","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.109.030197_bib7","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.taap.2008.04.024","article-title":"Expression profiling of interindividual variability following xenobiotic exposures in primary human hepatocyte cultures","volume":"231","author":"Goyak","year":"2008","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.109.030197_bib8","doi-asserted-by":"crossref","first-page":"15655","DOI":"10.1073\/pnas.232137699","article-title":"Infection of a human hepatoma cell line by hepatitis B virus","volume":"99","author":"Gripon","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1124\/dmd.109.030197_bib9","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0309-1651(82)90187-4","article-title":"High yield preparation of isolated human adult hepatocytes by enzymatic perfusion of the liver","volume":"6","author":"Guguen-Guillouzo","year":"1982","journal-title":"Cell Biol Int Rep"},{"issue":"Suppl 2","key":"10.1124\/dmd.109.030197_bib10","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1289\/ehp.98106511","article-title":"Liver cell models in in vitro toxicology","volume":"106","author":"Guillouzo","year":"1998","journal-title":"Environ Health Perspect"},{"key":"10.1124\/dmd.109.030197_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem Biol Interact"},{"key":"10.1124\/dmd.109.030197_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/03602530601093489","article-title":"Primary hepatocytes: current understanding of the regulation of metabolic enzymes and transporter proteins, and pharmaceutical practice for the use of hepatocytes in metabolism, enzyme induction, transporter, clearance, and hepatotoxicity studies","volume":"39","author":"Hewitt","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.109.030197_bib13","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1124\/dmd.106.010033","article-title":"Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes","volume":"34","author":"Jigorel","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1124\/dmd.107.019901","article-title":"Long-term functional stability of human HepaRG hepatocytes and use for chronic toxicity and genotoxicity studies","volume":"36","author":"Joss\u00e9","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib15","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1124\/dmd.107.020016","article-title":"Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1124\/dmd.107.017418","article-title":"HepaRG cells as an in vitro model for evaluation of cytochrome P450 induction in humans","volume":"36","author":"Kanebratt","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib17","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1002\/rcm.2110","article-title":"High-throughput screening of inhibitory potential of nine cytochrome P450 enzymes in vitro using liquid chromatography\/tandem mass spectrometry","volume":"19","author":"Kim","year":"2005","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1124\/dmd.109.030197_bib18","first-page":"853","article-title":"Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms","volume":"25","author":"Ko","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2174\/138920008783331112","article-title":"Strategies to in vitro assessment of major human CYP enzyme activities by using liquid chromatography tandem mass spectrometry","volume":"9","author":"Lahoz","year":"2008","journal-title":"Curr Drug Metab"},{"key":"10.1124\/dmd.109.030197_bib20","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2174\/187231208785425845","article-title":"Assessment of cytochrome P450 induction in human hepatocytes using the cocktail strategy plus liquid chromatography tandem mass spectrometry","volume":"2","author":"Lahoz","year":"2008","journal-title":"Drug Metab Lett"},{"key":"10.1124\/dmd.109.030197_bib21","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.taap.2008.11.008","article-title":"Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells","volume":"234","author":"Lambert","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/dmd.109.030197_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ejps.2006.01.004","article-title":"Functional expression of sinusoidal and canalicular hepatic drug transporters in the differentiated human hepatoma HepaRG cell line","volume":"28","author":"Le Vee","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.109.030197_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/dmd.31.4.421","article-title":"Effects of prototypical microsomal enzyme inducers on cytochrome P450 expression in cultured human hepatocytes","volume":"31","author":"Madan","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib24","doi-asserted-by":"crossref","first-page":"45904","DOI":"10.1074\/jbc.M207841200","article-title":"Identification of a 16-nucleotide sequence that mediates post-transcriptional regulation of rat CYP2E1 by insulin","volume":"277","author":"Moncion","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1124\/dmd.109.030197_bib25","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1432-1033.1990.tb19140.x","article-title":"Expression of cytochrome P-450 enzymes in cultured human hepatocytes","volume":"191","author":"Morel","year":"1990","journal-title":"Eur J Biochem"},{"key":"10.1124\/dmd.109.030197_bib26","first-page":"231","article-title":"Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones","volume":"53","author":"Morel","year":"1993","journal-title":"Cancer Res"},{"key":"10.1124\/dmd.109.030197_bib27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2133\/dmpk.23.45","article-title":"Comparison of inducibility of sulfotransferase and UDP-glucuronosyltransferase mRNAs by prototypical microsomal enzyme inducers in primary cultures of human and cynomolgus monkey hepatocytes","volume":"23","author":"Nishimura","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/dmd.109.030197_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2044.1996.tb07785.x","article-title":"What changes drug metabolism in critically ill patients\u2013III? Effect of pre-existing disease on the metabolism of midazolam","volume":"51","author":"Park","year":"1996","journal-title":"Anaesthesia"},{"key":"10.1124\/dmd.109.030197_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s00204-008-0332-8","article-title":"Inhibition and induction of human cytochrome P450 enzymes: current status","volume":"82","author":"Pelkonen","year":"2008","journal-title":"Arch Toxicol"},{"key":"10.1124\/dmd.109.030197_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/dmd.32.1.140","article-title":"An assessment of UDP-glucuronosyltransferase induction using primary human hepatocytes","volume":"32","author":"Soars","year":"2004","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/dmd.109.030197_bib31","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/jms.1239","article-title":"In vitro interaction cocktail assay for nine major cytochrome P450 enzymes with 13 probe reactions and a single LC\/MSMS run: analytical validation and testing with monoclonal anti-CYP antibodies","volume":"42","author":"Tolonen","year":"2007","journal-title":"J Mass Spectrom"},{"key":"10.1124\/dmd.109.030197_bib32","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.tiv.2009.03.008","article-title":"Functional expression, inhibition and induction of CYP enzymes in HepaRG cells","volume":"23","author":"Turpeinen","year":"2009","journal-title":"Toxicol In Vitro"},{"key":"10.1124\/dmd.109.030197_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejps.2004.10.006","article-title":"Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay","volume":"24","author":"Turpeinen","year":"2005","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/dmd.109.030197_bib34","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/0091270003261333","article-title":"\u201cCocktail\u201d approaches and strategies in drug development: valuable tool or flawed science?","volume":"44","author":"Zhou","year":"2004","journal-title":"J Clin Pharmacol"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624023134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624023134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.109.030197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T11:47:54Z","timestamp":1739879274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624023134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0090955624023134"],"URL":"https:\/\/doi.org\/10.1124\/dmd.109.030197","relation":{},"ISSN":["0090-9556"],"issn-type":[{"value":"0090-9556","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stable Expression, Activity, and Inducibility of Cytochromes P450 in Differentiated HepaRG Cells","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.109.030197","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}